NFKB1-94 insertion/deletion ATTG polymorphism contributes to risk of systemic lupus erythematosus

DNA and Cell Biology

Volumn 31, Issue 4, 2012, Pages 611-615

  Gao, Ming ^a   Wang, Chun Hui ^b   Sima, Xiutian ^c   Han, Xue Mei ^a  

^a CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^b Jilin Province Hospital   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; FEMALE; GENE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NFKB1 GENE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDEL MUTATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; NF-KAPPA B P50 SUBUNIT; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK FACTORS; SEQUENCE ANALYSIS, DNA;

EID: 84859782588     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1389     Document Type: Article

References (38)

1. Ballard, D.W., Dixon, E.P., Peffer, N.J., Bogerd, H., Doerre, S., Stein, B., and Greene, W.C. (1992). The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression. Proc Natl Acad Sci U S A 89, 1875-1879.
2. Barnes, P.J., and Karin, M. (1997). Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336, 1066-1071.
3. Borm, M.E., van Bodegraven, A.A., Mulder, C.J., Kraal, G., and Bouma, G. (2005). A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis. Int J Immunogenet 32, 401-405.
4. Cervera, R., Khamashta, M.A., Font, J., Sebastiani, G.D., Gil, A., Lavilla, P., Mejia, J.C., Aydintug, A.O., Chwalinska-Sadowska, H., de Ramon, E., Fernandez-Nebro, A., Galeazzi, M., Valen, M., Mathieu, A., Houssiau, F., Caro, N., Alba, P., Ramos-Casals, M., Ingelmo, M., and Hughes, G.R. (2003). Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82, 299-308.
5. Chen, F., Castranova, V., Shi, X., and Demers, L.M. (1999). New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 45, 7-17.
6. Dieguez-Gonzalez, R., Akar, S., Calaza, M., Perez-Pampin, E., Costas, J., Torres, M., Vicario, J.L., Velloso, M.L., Navarro, F., Narvaez, J., Joven, B., Herrero-Beaumont, G., Gonzalez-Alvaro, I., Fernandez-Gutierrez, B., de la Serna, A.R., Carreno, L., Lopez-Longo, J., Caliz, R., Collado-Escobar, M.D., Blanco, F.J., Fernandez-Lopez, C., Balsa, A., Pascual-Salcedo, D., Gomez-Reino, J.J., and Gonzalez, A. (2009). Genetic variation in the nuclear factor kappaB pathway in relation to susceptibility to rheumatoid arthritis. Ann Rheum Dis 68, 579-583.
7. Glas, J., Torok, H.P., Tonenchi, L., Muller-Myhsok, B., Mussack, T., Wetzke, M., Klein, W., Epplen, J.T., Griga, T., Schiemann, U., Lohse, P., Seiderer, J., Schnitzler, F., Brand, S., Ochsenkuhn, T., Folwaczny, M., and Folwaczny, C. (2006). Role of the NFKB1 - 94ins/delATTG promoter polymorphism in IBD and potential interactions with polymorphisms in the CARD15/NOD2, IKBL, and IL-1RN genes. Inflamm Bowel Dis 12, 606-611.
8. Gross, J.A., Johnston, J., Mudri, S., Enselman, R., Dillon, S.R., Madden, K., Xu, W., Parrish-Novak, J., Foster, D., Lofton-Day, C., Moore, M., Littau, A., Grossman, A., Haugen, H., Foley, K., Blumberg, H., Harrison, K., Kindsvogel, W., and Clegg, C.H. (2000). TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404, 995-999.
9. Hilliard, B.A., Mason, N., Xu, L., Sun, J., Lamhamedi-Cherradi, S.E., Liou, H.C., Hunter, C., and Chen, Y.H. (2002). Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation. J Clin Invest 110, 843-850.
10. Hochberg, M.C. (1997). Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40, 1725.
11. Ishikawa, H., Claudio, E., Dambach, D., Raventos-Suarez, C., Ryan, C., and Bravo, R. (1998). Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-kappaB1) but expressing p50. J Exp Med 187, 985-996.
12. Johnson, A.E., Gordon, C., Palmer, R.G., and Bacon, P.A. (1995). The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum 38, 551-558.
13. Karban, A.S., Okazaki, T., Panhuysen, C.I., Gallegos, T., Potter, J.J., Bailey-Wilson, J.E., Silverberg, M.S., Duerr, R.H., Cho, J.H., Gregersen, P.K., Wu, Y., Achkar, J.P., Dassopoulos, T., Mezey, E., Bayless, T.M., Nouvet, F.J., and Brant, S.R. (2004). Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 13, 35-45.
14. Kurylowicz, A., Hiromatsu, Y., Jurecka-Lubieniecka, B., Kula, D., Kowalska, M., Ichimura, M., Koga, H., Kaku, H., Bar-Andziak, E., Nauman, J., Jarzab, B., Ploski, R., and Bednarczuk, T. (2007). Association of NFKB1 - 94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease. Genes Immun 8, 532-538.
15. Kurylowicz, A., and Nauman, J. (2008). The role of nuclear factor-kappaB in the development of autoimmune diseases: a link between genes and environment. Acta Biochim Pol 55, 629-647.
16. Kyogoku, C., Langefeld, C.D., Ortmann, W.A., Lee, A., Selby, S., Carlton, V.E., Chang, M., Ramos, P., Baechler, E.C., Batliwalla, F.M., Novitzke, J., Williams, A.H., Gillett, C., Rodine, P., Graham, R.R., Ardlie, K.G., Gaffney, P.M., Moser, K.L., Petri, M., Begovich, A.B., Gregersen, P.K., and Behrens, T.W. (2004). Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 75, 504-507.
17. Li, Q., and Verma, I.M. (2002). NF-kappaB regulation in the immune system. Nat Rev Immunol 2, 725-734.
18. Martinez, A., Sanchez, E., Valdivia, A., Orozco, G., Lopez-Nevot, M.A., Pascual-Salcedo, D., Balsa, A., Fernandez-Gutierrez, B., de la Concha, E.G., Garcia-Sanchez,A., Koeleman, B.P., Urcelay, E., and Martin, J. (2006). Epistatic interaction between FCRL3 and NFkappaB1 genes in Spanish patients with rheumatoid arthritis. Ann Rheum Dis 65, 1188-1191.
19. Mathew, S., Murty, V.V., Dalla-Favera, R., and Chaganti, R.S. (1993). Chromosomal localization of genes encoding the transcription factors, c-rel, NF-kappa Bp50, NF-kappa Bp65, and lyt-10 by fluorescence in situ hybridization. Oncogene 8, 191-193.
20. Mirza, M.M., Fisher, S.A., Onnie, C., Lewis, C.M., Mathew, C.G., Sanderson, J., and Forbes, A. (2005). No association of the NFKB1 promoter polymorphism with ulcerative colitis in a British case control cohort. Gut 54, 1205-1206.
21. Mok, C.C., and Lau, C.S. (2003). Pathogenesis of systemic lupus erythematosus. J Clin Pathol 56, 481-490.
22. Oikonomidou, O., Vlachoyiannopoulos, P.G., Kominakis, A., Kalofoutis, A., Moutsopoulos, H.M., and Moutsatsou, P. (2006). Glucocorticoid receptor, nuclear factor kappaB, activator protein-1 and C-jun N-terminal kinase in systemic lupus erythematosus patients. Neuroimmunomodulation 13, 194-204.
23. Oliver, J., Gomez-Garcia, M., Paco, L., Lopez-Nevot, M.A., Pinero, A., Correro, F., Martin, L., Brieva, J.A., Nieto, A., and Martin, J. (2005). A functional polymorphism of the NFKB1 promoter is not associated with ulcerative colitis in a Spanish population. Inflamm Bowel Dis 11, 576-579.
24. Orozco, G., Sanchez, E., Collado, M.D., Lopez-Nevot, M.A., Paco, L., Garcia, A., Jimenez-Alonso, J., and Martin, J. (2005). Analysis of the functional NFKB1 promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 65, 183-186.
25. Ouaaz, F., Arron, J., Zheng, Y., Choi, Y., and Beg, A.A. (2002). Dendritic cell development and survival require distinct NFkappaB subunits. Immunity 16, 257-270.
26. Rahman, A., and Isenberg, D.A. (2008). Systemic lupus erythematosus. N Engl J Med 358, 929-939.
27. Saccani, S., Pantano, S., and Natoli, G. (2003). Modulation of NF-kappaB activity by exchange of dimers. Mol Cell 11, 1563-1574.
28. Sen, R., and Baltimore, D. (1986). Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell 47, 921-928.
29. Tak, P.P., and Firestein, G.S. (2001). NF-kappaB: a key role in inflammatory diseases. J Clin Invest 107, 7-11.
30. Tan, E.M., Cohen, A.S., Fries, J.F., Masi, A.T., McShane, D.J., Rothfield, N.F., Schaller, J.G., Talal, N., and Winchester, R.J. (1982). The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25, 1271-1277.
31. Tan, P.H., Sagoo, P., Chan, C., Yates, J.B., Campbell, J., Beutelspacher, S.C., Foxwell, B.M., Lombardi, G., and George, A.J. (2005). Inhibition of NF-kappa B and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells. J Immunol 174, 7633-7644.
32. Warchol, T., Lianeri, M., Wudarski, M., Lacki, J.K., and Jagodzinski, P.P. (2009). IL-18 105 A
33. Weih, F., Carrasco, D., Durham, S.K., Barton, D.S., Rizzo, C.A., Ryseck, R.P., Lira, S.A., and Bravo, R. (1995). Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family. Cell 80, 331-340.
34. Wong, H.K., Kammer, G.M., Dennis, G., and Tsokos, G.C. (1999). Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression. J Immunol 163, 1682-1689.
35. Xue, H., Gao, L., Wu, Y., Fang, W., Wang, L., Li, C., Li, Y., Liang, W., and Zhang, L. (2009). The IL-16 gene polymorphisms and the risk of the systemic lupus erythematosus. Clin Chim Acta 403, 223-225.
36. Zanetti, M., Castiglioni, P., Schoenberger, S., and Gerloni, M. (2003). The role of relB in regulating the adaptive immune response. Ann N Y Acad Sci 987, 249-257.
37. Zhou, B., Qie, M., Wang, Y., Yan, L., Zhang, Z., Liang, A., Wang, T., Wang, X., Song, Y., and Zhang, L. (2010). Relationship between NFKB1 - 94 insertion/deletion ATTG polymorphism and susceptibility of cervical squamous cell carcinoma risk. Ann Oncol 21, 506-511.
38. Zou, Y.F., Wang, F., Feng, X.L., Tao, J.H., Zhu, J.M., Pan, F.M., and Su, H. (2011). Association of NFKB1 - 94ins/delATTG promoter polymorphism with susceptibility to autoimmune and inflammatory diseases: a meta-analysis. Tissue Antigens 77, 9-17.